CRBN Stock Overview
Provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Corbion N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €21.38 |
| 52 Week High | €26.98 |
| 52 Week Low | €15.73 |
| Beta | 0.98 |
| 1 Month Change | -2.82% |
| 3 Month Change | -9.33% |
| 1 Year Change | 10.43% |
| 3 Year Change | -46.36% |
| 5 Year Change | -24.98% |
| Change since IPO | -18.30% |
Recent News & Updates
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
Dec 18
Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Nov 18An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Oct 31Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For Corbion N.V. (AMS:CRBN)
Dec 18Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Nov 18An Intrinsic Calculation For Corbion N.V. (AMS:CRBN) Suggests It's 26% Undervalued
Oct 31Corbion (AMS:CRBN) Takes On Some Risk With Its Use Of Debt
Sep 26The Price Is Right For Corbion N.V. (AMS:CRBN)
Jul 18Corbion N.V. (AMS:CRBN) Shares Could Be 25% Below Their Intrinsic Value Estimate
Jun 20Here's Why Shareholders Should Examine Corbion N.V.'s (AMS:CRBN) CEO Compensation Package More Closely
May 08Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Apr 17Investor Optimism Abounds Corbion N.V. (AMS:CRBN) But Growth Is Lacking
Jan 20Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Dec 18Estimating The Fair Value Of Corbion N.V. (AMS:CRBN)
Nov 04Corbion (AMS:CRBN) Has A Somewhat Strained Balance Sheet
Sep 13Returns On Capital Signal Tricky Times Ahead For Corbion (AMS:CRBN)
Aug 04When Should You Buy Corbion N.V. (AMS:CRBN)?
Jul 14Corbion N.V. (AMS:CRBN) Shares Could Be 22% Above Their Intrinsic Value Estimate
Jun 04Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Apr 21Corbion (AMS:CRBN) Is Paying Out A Dividend Of €0.56
Mar 10Is Now An Opportune Moment To Examine Corbion N.V. (AMS:CRBN)?
Feb 22Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Jan 26Is Corbion (AMS:CRBN) Using Too Much Debt?
Dec 20Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Nov 24Should You Think About Buying Corbion N.V. (AMS:CRBN) Now?
Nov 09Corbion (AMS:CRBN) Might Be Having Difficulty Using Its Capital Effectively
Oct 08Here's Why Corbion (AMS:CRBN) Has A Meaningful Debt Burden
Sep 19A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Aug 23Is It Time To Consider Buying Corbion N.V. (AMS:CRBN)?
Jul 21Investors Could Be Concerned With Corbion's (AMS:CRBN) Returns On Capital
Jul 06Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56
May 20Calculating The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
May 17Corbion (AMS:CRBN) Is Due To Pay A Dividend Of €0.56
Apr 28Corbion (AMS:CRBN) Has Announced A Dividend Of €0.56
Apr 07Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Mar 26Corbion (AMS:CRBN) Has Affirmed Its Dividend Of €0.56
Feb 27Does Corbion (AMS:CRBN) Have A Healthy Balance Sheet?
Feb 27At €37.02, Is Corbion N.V. (AMS:CRBN) Worth Looking At Closely?
Feb 13A Look At The Intrinsic Value Of Corbion N.V. (AMS:CRBN)
Jan 26Here's Why I Think Corbion (AMS:CRBN) Is An Interesting Stock
Dec 22Corbion's (AMS:CRBN) Returns On Capital Not Reflecting Well On The Business
Dec 10Is Corbion N.V. (AMS:CRBN) Worth €40.3 Based On Its Intrinsic Value?
Oct 25We Think Corbion (AMS:CRBN) Is Taking Some Risk With Its Debt
Sep 21Corbion (AMS:CRBN) Could Be Struggling To Allocate Capital
Sep 01I Ran A Stock Scan For Earnings Growth And Corbion (AMS:CRBN) Passed With Ease
Aug 17Shareholder Returns
| CRBN | NL Chemicals | NL Market | |
|---|---|---|---|
| 7D | -2.1% | -4.9% | -1.3% |
| 1Y | 10.4% | -10.2% | 3.6% |
Return vs Industry: CRBN exceeded the Dutch Chemicals industry which returned -10.2% over the past year.
Return vs Market: CRBN exceeded the Dutch Market which returned 3.6% over the past year.
Price Volatility
| CRBN volatility | |
|---|---|
| CRBN Average Weekly Movement | 3.8% |
| Chemicals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in NL Market | 6.9% |
| 10% least volatile stocks in NL Market | 2.3% |
Stable Share Price: CRBN has not had significant price volatility in the past 3 months compared to the Dutch market.
Volatility Over Time: CRBN's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 2,727 | Olivier Rigaud | www.corbion.com |
Corbion N.V. provides lactic acid and lactic acid derivatives, other ferment, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. It offers ingredient solutions for the food, home and personal care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics markets. The company markets its products through a network of sales offices and distributors.
Corbion N.V. Fundamentals Summary
| CRBN fundamental statistics | |
|---|---|
| Market cap | €1.25b |
| Earnings (TTM) | €80.10m |
| Revenue (TTM) | €1.44b |
15.5x
P/E Ratio0.9x
P/S RatioIs CRBN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRBN income statement (TTM) | |
|---|---|
| Revenue | €1.44b |
| Cost of Revenue | €1.10b |
| Gross Profit | €341.30m |
| Other Expenses | €261.20m |
| Earnings | €80.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 1.38 |
| Gross Margin | 23.71% |
| Net Profit Margin | 5.57% |
| Debt/Equity Ratio | 58.5% |
How did CRBN perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield45%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 18:38 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Corbion N.V. is covered by 24 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Jan Vos | ABN AMRO Bank N.V. |
| Setu Sharda | Barclays |
| Fintan Ryan | Berenberg |